.png)
Label-free Detection (lfd) Market By Product And End User - Global Industry Analysis And Forecast To 2023
Published On : May 2022 Pages : 90 Category: Biotechnology Report Code : HC05739
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook and Trend Analysis
The Label-free Detection (LFD) Market was worth USD 0.71 billion in 2017 and is expected to reach approximately USD 1.47 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 8.42% during the forecast period. The ascent in the event of chronic diseases, for example, respiratory illnesses, chronic kidney ailments, and leukemia have expanded the requirement for drug discovery. Various drug discovery programs are consucted by a few scholastic and research foundations around the globe. Drug advancement predominantly helps in testing the harmfulness of medication and adequacy at the objective tissue or organ in a patient. Besides, the development in drug discovery has likewise prompted an appeal for customized prescriptions and the market is additionally seeing an ascent in associations between academic research organizations and major pharmaceutical and biotechnology organizations.
Product Outlook and Trend Analysis
The biochemical assays fragment represented the main shares of the LFD market in 2017. The accessibility of wide test menus for biochemical measures is one of the main considerations powering the development of the LFD market in this section.
End User Outlook and Trend Analysis
The pharmaceutical and biotechnology segments were the significant end-users to the LFD market amid 2017. The expansion in medicate revelation and product enhancement and the rising associations with academic and research organizations; will drive the development of the LFD market in this end-use portion amid the following couple of years.
Regional Outlook and Trend Analysis
The Americas will be the revenue contributor of the LFD market all through the conjecture time frame. This is majorly because of the expanding pervasiveness of infections and the development in medicating revelation programs in the locale. Partnerships between academic institutes and huge organizations and the existence of a few pharmaceutical and biotechnological organizations, will likewise support the market's development in the Americas.
Competitive Insights
The leading players in the market are Pall Corporation, AMETEK Inc, Bio-Rad Laboratories, Roche Holding AG, Juno Therapeutics, Attana, Corning Technologies Pvt Ltd and Wipro GE Healthcare Pvt Ltd. The market is observing an expansion in competition because of the existence of various worldwide and local sellers. Sellers are engaging themselves in the advancement of various products and are concentrating on R&D activities and acquisitions.
The Label-free Detection (LFD) Market is segmented as follows-
By Product:
- Cell-based assays
- Biochemical assays
By End User:
- Academic and research institutes
- Pharmaceutical and biotechnology companies
- CROs
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Label-free Detection (LFD) Market, By Product, Estimates and Forecast, 2014-2023 ($Million)
· Biochemical Assays
· Cell-Based Assays
· Label-free Detection (LFD) Market, By End User, Estimates and Forecast, 2014-2023 ($Million)
· Pharmaceutical and Biotechnology Companies
· CROs
· Academic and Research Institutes
· Label-free Detection (LFD) Market, By Region, Estimates and Forecast, 2014-2023 ($Million)
· North America
§ North America Label-free Detection (LFD) Market, By Country
o U.S. Label-free Detection (LFD) Market
o Canada Label-free Detection (LFD) Market
o Mexico Label-free Detection (LFD) Market
· Europe
§ Europe Label-free Detection (LFD) Market, By Country
o Germany Label-free Detection (LFD) Market
o UK Label-free Detection (LFD) Market
o France Label-free Detection (LFD) Market
o Russia Label-free Detection (LFD) Market
o Italy Label-free Detection (LFD) Market
o Rest of Europe Label-free Detection (LFD) Market
· Asia-Pacific
§ Asia-Pacific Label-free Detection (LFD) Market, By Country
o China Label-free Detection (LFD) Market
o Japan Label-free Detection (LFD) Market
o South Korea Label-free Detection (LFD) Market
o India Label-free Detection (LFD) Market
o Southeast Asia Label-free Detection (LFD) Market
o Rest of Asia-Pacific Label-free Detection (LFD) Market
· South America
§ South America Label-free Detection (LFD) Market
o Brazil Label-free Detection (LFD) Market
o Argentina Label-free Detection (LFD) Market
o Columbia Label-free Detection (LFD) Market
o South Africa Label-free Detection (LFD) Market
o Rest of South America Label-free Detection (LFD) Market
· Middle East and Africa
§ Middle East and Africa Label-free Detection (LFD) Market
o Saudi Arabia Label-free Detection (LFD) Market
o UAE Label-free Detection (LFD) Market
o Egypt Label-free Detection (LFD) Market
o Nigeria Label-free Detection (LFD) Market
o South Africa Label-free Detection (LFD) Market
o Rest of MEA Label-free Detection (LFD) Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Increasing Penetration in Medical Products
3.2.1.2. Growth of Water Treatment Industry
3.2.2. Restraints
3.2.2.1. Stringent Government Regulations
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Label-free Detection (LFD) Market, By Product
5.1. Introduction
5.2. Global Label-free Detection (LFD) Sales, Revenue and Market Share by Product (2017-2017)
5.2.1. Global Label-free Detection (LFD) Sales and Sales Share by Product (2017-2017)
5.2.2. Global Label-free Detection (LFD) Revenue and Revenue Share by Product (2017-2017)
5.3. Label-free Detection (LFD) Market Assessment and Forecast, By Product, 2017-2023
5.4. Biochemical assays
5.4.1. Global Biochemical assays Sales and Growth Rate (2017-2027)
5.5. Cell-based assays
5.5.1. Global Cell-based assays Sales and Growth Rate (2017-2027)
6. Label-free Detection (LFD) Market, By End User
6.1. Introduction
6.2. Global Label-free Detection (LFD) Sales, Revenue and Market Share by End User (2017-2017)
6.2.1. Global Label-free Detection (LFD) Sales and Sales Share by End User (2017-2017)
6.2.2. Global Label-free Detection (LFD) Revenue and Revenue Share by End User (2017-2017)
6.3. The Label-free Detection (LFD) Market Assessment and Forecast, By End User, 2017-2023
6.4. Pharmaceutical and Biotechnology Companies
6.4.1. Global Pharmaceutical and Biotechnology Companies Sales and Growth Rate (2017-2027)
6.5. CROs
6.5.1. Global CROs Sales and Growth Rate (2017-2027)
6.6. Academic and Research Institutes
6.6.1. Global Academic and Research Institutes Sales and Growth Rate (2017-2027)
7. Label-free Detection (LFD) Market , By Region
7.1. Introduction
7.2. Global Label-free Detection (LFD) Sales, Revenue and Market Share by Regions
7.2.1. Global Label-free Detection (LFD) Sales by Regions (2017-2027)
7.2.2. Global Label-free Detection (LFD) Revenue by Regions (2017-2027)
7.3. North America Label-free Detection (LFD) by Countries
7.3.1. North America Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.3.2. North America Label-free Detection (LFD) Revenue and Growth Rate (2017-2027)
7.3.3. North America Label-free Detection (LFD) Sales by Countries (2017-2027)
7.3.4. North America Label-free Detection (LFD) Revenue (Million USD) by Countries (2017-2027)
7.3.5. U.S.
7.3.5.1. United States Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.3.5.2. United States Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.6. Canada
7.3.6.1. Canada Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.3.6.2. Canada Label-free Detection (LFD) Sales (Millions USD) and Growth Rate (2017-2027)
7.3.7. Mexico
7.3.7.1. Mexico Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.3.7.2. Mexico Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Label-free Detection (LFD) by Countries
7.4.1. Europe Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.4.2. Europe Label-free Detection (LFD) Revenue and Growth Rate (2017-2027)
7.4.3. Europe Label-free Detection (LFD) Sales by Countries (2017-2027)
7.4.4. Europe Label-free Detection (LFD) Revenue (Million USD) by Countries (2017-2027)
7.4.5. Germany
7.4.5.1. Germany Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.4.5.2. Germany Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. UK
7.4.6.1. UK Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.4.6.2. UK Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. France
7.4.7.1. France Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.4.7.2. France Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Russia
7.4.8.1. Russia Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.4.8.2. Russia Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.9. Italy
7.4.9.1. Italy Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.4.9.2. Italy Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.10. Rest of Europe
7.4.10.1. Rest of Europe Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.4.10.2. Rest of Europe Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific
7.5.1. Asia-Pacific Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Label-free Detection (LFD) Revenue and Growth Rate (2017-2027)
7.5.3. Asia-Pacific Label-free Detection (LFD) Sales by Countries (2017-2027)
7.5.4. Asia-Pacific Label-free Detection (LFD) Revenue (Million USD) by Countries (2017-2027)
7.5.5. China
7.5.5.1. China Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.5.5.2. China Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. Japan
7.5.6.1. Japan Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.5.6.2. Japan Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6.3.
7.5.7. Korea
7.5.7.1. Korea Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.5.7.2. Korea Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. India
7.5.8.1. India Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.5.8.2. India Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.9. Southeast Asia
7.5.9.1. Southeast Asia Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.5.9.2. Southeast Asia Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.10. Rest of Asia-Pacific
7.5.10.1. Rest of Asia-Pacific Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.5.10.2. Rest of Asia-Pacific Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America
7.6.1. South America Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.6.2. South America Label-free Detection (LFD) Revenue and Growth Rate (2017-2027)
7.6.3. South America Label-free Detection (LFD) Sales by Countries (2017-2027)
7.6.4. South America Label-free Detection (LFD) Revenue (Million USD) by Countries (2017-2027)
7.6.5. Brazil
7.6.5.1. Brazil Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.6.5.2. Brazil Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Argentina
7.6.6.1. Argentina Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.6.6.2. Argentina Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.7. Columbia
7.6.7.1. Columbia Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.6.7.2. Columbia Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.8. Rest of South America
7.6.8.1. Rest of South America Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.6.8.2. Rest of South America Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa
7.7.1. Middle East and Africa Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Label-free Detection (LFD) Revenue and Growth Rate (2017-2027)
7.7.3. Middle East and Africa Label-free Detection (LFD) Sales by Countries (2017-2027)
7.7.4. Middle East and Africa Label-free Detection (LFD) Revenue (Million USD) by Countries (2017-2027)
7.7.5. Saudi Arabia
7.7.5.1. Saudi Arabia Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.7.5.2. Saudi Arabia Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. United Arab Emirates
7.7.6.1. United Arab Emirates Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.7.6.2. United Arab Emirates Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. Egypt
7.7.7.1. Egypt Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.7.7.2. Egypt Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Nigeria
7.7.8.1. Nigeria Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.7.8.2. Nigeria Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. South Africa
7.7.9.1. South Africa Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.7.9.2. South Africa Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.10. Rest of Middle East and Africa
7.7.10.1. Rest of Middle East and Africa Label-free Detection (LFD) Sales and Growth Rate (2017-2027)
7.7.10.2. Rest of Middle East and Africa Label-free Detection (LFD) Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Bio-Rad Laboratories
8.1.1. Business Overview
8.1.2. Product Portfolio
8.1.3. Strategic Developments
8.1.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.2. GE Healthcare
8.2.1. Business Overview
8.2.2. Product Portfolio
8.2.3. Strategic Developments
8.2.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.3. F.Hoffman-La Roche
8.3.1. Business Overview
8.3.2. Product Portfolio
8.3.3. Strategic Developments
8.3.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.4. AMETEK
8.4.1. Business Overview
8.4.2. Product Portfolio
8.4.3. Strategic Developments
8.4.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.5. Attana
8.5.1. Business Overview
8.5.2. Product Portfolio
8.5.3. Strategic Developments
8.5.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.6. BiOptix
8.6.1. Business Overview
8.6.2. Product Portfolio
8.6.3. Strategic Developments
8.6.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.7. Corning
8.7.1. Business Overview
8.7.2. Product Portfolio
8.7.3. Strategic Developments
8.7.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.8. Juno Therapeutics
8.8.1. Business Overview
8.8.2. Product Portfolio
8.8.3. Strategic Developments
8.8.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.9. Pall
8.9.1. Business Overview
8.9.2. Product Portfolio
8.9.3. Strategic Developments
8.9.4. Label-free Detection (LFD) Sales, Revenue and Market Share
8.10. SymCel
8.10.1. Business Overview
8.10.2. Product Portfolio
8.10.3. Strategic Developments
8.10.4. Label-free Detection (LFD) Sales, Revenue and Market Share
9. Global Label-free Detection (LFD) Market Competition, by Manufacturer
9.1. Global Label-free Detection (LFD) Sales and Market Share by Manufacturer (2017-2017)
9.2. Global Label-free Detection (LFD) Revenue and Market Share by Manufacturer (2017-2017)
9.3. Top 5 Label-free Detection (LFD) Manufacturer Market Share
9.4. Market Competition Trend
10. Label-free Detection (LFD) Market Forecast (2027-2023)
10.1. Global Label-free Detection (LFD) Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
10.2. Label-free Detection (LFD) Market Forecast by Regions (2027-2023)
10.2.1. North America Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.1.1. United States Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.1.2. Canada Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.1.3. Mexico Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.2. Europe Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.2.1. Germany Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.2.2. United Kingdom Label-free Detection (LFD)s Market Forecast (2027-2023)
10.2.2.3. France Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.2.4. Russia Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.2.5. Italy Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.2.6. Rest of the Europe Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.3. Asia-Pacific Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.3.1. China Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.3.2. Japan Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.3.3. Korea Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.3.4. India Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.3.5. Southeast Asia Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.3.6. Rest of Asia-Pacific Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.4. South America Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.4.1. Brazil Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.4.2. Argentina Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.4.3. Columbia Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.4.4. Rest of South America Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.5. Middle East and Africa Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.5.1. Saudi Arabia Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.5.2. UAE Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.5.3. Egypt Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.5.4. Nigeria Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.5.5. South Africa Label-free Detection (LFD) Market Forecast (2027-2023)
10.2.5.6. Rest of MEA Label-free Detection (LFD) Market Forecast (2027-2023)
10.3. Label-free Detection (LFD) Market Forecast by Product (2027-2023)
10.3.1. Global Label-free Detection (LFD) Sales Forecast by Product (2027-2023)
10.3.2. Global Label-free Detection (LFD) Sales Market Share Forecast by Product (2027-2023)
10.4. Label-free Detection (LFD) Market Forecast by End User (2027-2023)
10.4.1. Global Label-free Detection (LFD) Sales Forecast by End User (2027-2023)
10.4.2. Global Label-free Detection (LFD) Sales Market Share Forecast by End User (2027-2023)
List of Tables and Figures
*You can glance through the list of Tables and Figures when you view the sample copy of Label-free Detection (LFD) Market.
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Label-free Detection (LFD) Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|